Therapeutic	O
Electromagnetic	O
Field	O
(	O
TEMF	O
)	O
and	O
gamma	O
irradiation	O
on	O
human	O
breast	B-Cancer
cancer	I-Cancer
xenograft	I-Cancer
growth	O
,	O
angiogenesis	O
and	O
metastasis	O
.	O

BACKGROUND	O
:	O
The	O
effects	O
of	O
a	O
rectified	O
semi	O
-	O
sinewave	O
signal	O
(	O
15	O
mT	O
amplitude	O
,	O
120	O
pulses	O
per	O
second	O
,	O
EMF	O
Therapeutics	O
,	O
Inc	O
.	O
)	O
(	O
TEMF	O
)	O
alone	O
and	O
in	O
combination	O
with	O
gamma	O
irradiation	O
(	O
IR	O
)	O
therapy	O
in	O
nude	O
mice	O
bearing	O
a	O
human	O
MDA	B-Cancer
MB231	I-Cancer
breast	I-Cancer
cancer	I-Cancer
xenograft	I-Cancer
were	O
tested	O
.	O

Green	O
fluorescence	O
protein	O
transfected	O
cancer	B-Cell
cells	I-Cell
were	O
injected	O
into	O
the	O
mammary	B-Tissue
fat	I-Tissue
pad	I-Tissue
of	O
young	O
female	O
mice	O
.	O

Six	O
weeks	O
later	O
,	O
mice	O
were	O
randomly	O
divided	O
into	O
four	O
treatment	O
groups	O
:	O
untreated	O
controls	O
;	O
10	O
minute	O
daily	O
TEMF	O
;	O
200	O
cGy	O
of	O
IR	O
every	O
other	O
day	O
(	O
total	O
800	O
cGy	O
)	O
;	O
IR	O
plus	O
daily	O
TEMF	O
.	O

Some	O
mice	O
in	O
each	O
group	O
were	O
euthanized	O
24	O
hours	O
after	O
the	O
end	O
of	O
IR	O
.	O

TEMF	O
treatment	O
continued	O
for	O
3	O
additional	O
weeks	O
.	O

Tumor	B-Cancer
sections	I-Cancer
were	O
stained	O
for	O
:	O
endothelial	B-Cell
cells	I-Cell
with	O
CD31	O
and	O
PAS	O
or	O
hypoxia	O
inducible	O
factor	O
1alpha	O
(	O
HIF	O
)	O
.	O

RESULTS	O
:	O
Most	O
tumors	B-Cancer
less	O
than	O
35	O
mm3	O
were	O
white	O
but	O
tumors	B-Cancer
greater	O
than	O
35	O
mm3	O
were	O
pink	O
and	O
had	O
a	O
vascularized	O
capsule	B-Cancer
.	O

The	O
cortex	B-Cancer
within	O
100	O
microns	O
of	O
the	O
capsule	B-Cancer
had	O
little	O
vascularization	O
.	O

Blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
,	O
capillaries	B-Tissue
,	O
and	O
endothelial	B-Cellular_component
pseudopods	I-Cellular_component
were	O
found	O
at	O
greater	O
than	O
100	O
microns	O
from	O
the	O
capsule	B-Cancer
(	O
subcortex	B-Cancer
)	O
.	O

Tumors	B-Cancer
greater	O
than	O
35	O
mm3	O
treated	O
with	O
IR	O
24	O
hours	O
previously	O
or	O
with	O
TEMF	O
had	O
decreased	O
blood	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
in	O
the	O
subcortex	B-Cancer
and	O
more	O
endothelial	B-Cellular_component
pseudopods	I-Cellular_component
projecting	O
into	O
hypoxic	O
,	O
HIF	O
positive	O
areas	O
than	O
tumors	B-Cancer
from	O
the	O
control	O
group	O
.	O

Mice	O
that	O
received	O
either	O
IR	O
or	O
TEMF	O
had	O
significantly	O
fewer	O
lung	B-Cancer
metastatic	I-Cancer
sites	I-Cancer
and	O
slower	O
tumor	B-Cancer
growth	O
than	O
did	O
untreated	O
mice	O
.	O

No	O
harmful	O
side	O
effects	O
were	O
attributed	O
to	O
TEMF	O
.	O

CONCLUSION	O
:	O
TEMF	O
therapy	O
provided	O
a	O
safe	O
means	O
for	O
retarding	O
tumor	B-Cancer
vascularization	O
,	O
growth	O
and	O
metastasis	O
.	O

